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Left ventricular assist devices (LVADs) are systems for mechanical support for patients with end-stage heart failure. Preoperative,
postoperative and comprehensive followup with transthoracic echocardiography has a major role in LVAD patient management.
In this paper, we will present brieﬂy the hemodynamics of axial-ﬂow LVAD, the rationale, and available data for a complete
and organized echocardiographic assessment in these patients including preoperative assessment, postoperative and long-term
evaluation.
1.Introduction
Left ventricular assist devices (LVADs) are systems for
mechanical support for patients with end-stage heart failure.
They are eﬀective in supporting the circulation for weeks
to years as a bridge to transplant (BTT) or destination
therapy (DT) [1–4]. The newer axial-ﬂow devices have been
designed in an eﬀort to minimize operative risk, improve
durability, and lower the risk of device-related adverse
events by reducing the number of moving parts in the
device and device size [5–7]. Continuous axial ﬂow LVAD
can provide eﬀective hemodynamic support for prolonged
periods,improving functional statusandqualityoflife[8,9].
The designation axial ﬂow device refers speciﬁcally to the
design and shape of the impeller, and therefore the route by
which ﬂuid is accelerated. The impellers of axial ﬂow pumps
generallyaddenergybydeﬂecting ﬂowin thecircumferential
direction. Despite their small size, these pumps can provide
ﬂows of up to 8–10L/min, suﬃcient to support a large
adult patient. Currently, there are two major types of axial
pumps in the USA: Heartmate II (Heartmate II, Thoratec,
Pleasanton, CA) and Jarvic 2000 (Jarvik, New York City,
New York, USA). The Jarvik 2000 is an intraventricular axial
ﬂowpumpthatmeasures25mmindiameterby55mmin
length with a weight of approximately 85g. It consists of
the pump positioned inside the left ventricular cavity and
the outﬂow cannula which can be anastomosed to the right
anterior aspect of the ascending aorta or to the descending
aorta. The impeller rotates in the left ventricular cavity at
speeds of 8,000 to 12,000 revolutions per minute (RPM) to
deliver 2 to 7L/min. The pulse control circuit allows the user
to adjust the rotational speed of the pump manually.
The HeartMate II LVAD (Thoratec, Pleasanton, CA) is
a continuous, axial-ﬂow LVAD, positioned in succession to
the left ventricle (LV). It consists of a spinning rotor pump
as its lone moving part, an inﬂow cannula, an outﬂow
cannula, and a single driveline that exits percutaneously
towards the electronic controller [6, 7]. The inﬂow cannula
is inserted into the apex of the LV, and the outﬂow
cannula is anastomosed to the right anterior aspect of the
ascending aorta. The LVAD pump is placed within the
preperitoneal space. In both pumps, the percutaneous lead
carries the electrical cable to an electronic controler and
battery packs (one in the Jarvik and two in the HeartMate
II), which are worn on a belt and a shoulder holster,
respectively. The spinning rotor draws blood from the inﬂow2 Cardiology Research and Practice
cannula throughout cardiac diastole and systole, propelling
it into the aorta. Preoperative, postoperative, and followup
transthoracic echocardiography (TTE) has a major role in
LVAD patient management. In this paper, we will present
brieﬂy the hemodynamics of axial-ﬂow LVAD, focusing on
the HeartMate II, and the rationale and available data for
a comprehensive echocardiographic assessment in these
patients including preoperative assessment, postoperative
and long-term evaluation.
LVAD Performance Parameters. The system-provided pa-
rameters of speed, power, PI, and estimated ﬂow for the
HeartMate II serve as important indicators of proper LVAD
function. It is important to view each of these device
parameters in the context of the patient’s overall condition.
Once baseline values representing a good level of patient
support are established, the degree of change in a parameter
usually has more clinical signiﬁcance than its absolute
value. Brieﬂy, the pump speed will be determined during
a speed ramp study. Pump power is a direct measurement
of motor voltage and current. Increases in pump speed,
ﬂow, or physiological demand will increase pump power.
Speciﬁcally, gradual power increases, power values greater
than 10–12 watts, or abrupt changes in power should raise
concern for possible thrombus inside the pump. When the
LV contracts, the increase in ventricular pressure causes an
increase in pump ﬂow during systole. The magnitude of
these ﬂow changes is measured to produce the PI. The PI
represents cardiac pulsatility and is related to the magnitude
of assistance provided by the LVAD. Higher values indicate
more ventricular ﬁlling or better contractility (pump is
providing less support to the LV), while lowervaluesindicate
less ventricular ﬁlling or lower contractility. Pump ﬂow is
estimated based on power. Since it is a calculated value, it
becomes imprecise at low and high regions of the power-
ﬂow relationship. Therefore, any increase in power not
related to an increased ﬂow, such as thrombus, will cause an
erroneously high ﬂow. Conversely, an occlusion of ﬂow path
(inﬂow obstruction due to malposition or suction events)
will decrease power and calculated ﬂow. In either situation,
an independent assessment of pump output using the TTE
should be performed.
2.Evaluationof Axial-Flow
LVADHemodynamics
2.1. The “Tight Relation” between the LV, the Left Atrium, and
the Aorta . Axial-ﬂow pumps are connected in series to the
LV bythe inﬂow cannula, with the LV being the direct source
of preload essential for LVAD output. They continuously
unload the LV during the entire cardiac cycle, eliminating
the isometric contraction and relaxation phases of normal
cardiac activity. Although considered to be continuous ﬂow
assist devices, working in succession to the LV, the true
hemodynamic proﬁle depends on the pump speed, the LV
contractility, the preload, and the afterload conditions.
The volume of ﬂow generated by continuous ﬂow LVAD
is determined by the speed of the rotation of the pump
and by the diﬀerential pressure that exists across the device.
For a speciﬁed speed, ﬂow varies inversely with the pressure
diﬀerence [10]. The LVAD is connected to the circulation by
the inﬂow conduit on the LV apex, while the outﬂow graft is
secured to the aorta. With these connections, throughoutthe
cardiac cycle, the pump diﬀerential pressure is equal to the
aortic pressure minus the LV pressure. In other words, the
ﬂow increases with increasing LV pressure (LVAD preload),
or decreasing aortic pressure (LVADafterload). The dynamic
parameter that determines the pump’sdiﬀerential pressure is
the LV pressure, which in turnisdependentonits contractile
reserve. Even a severely depressed LV will have the possibility
to generate some residual rhythmic contraction that will
create pulse pressure. This pressure ﬂuctuation at the pump
inﬂow will change the pump diﬀerential pressure, which
in turn will alter the pump ﬂow. Therefore, any residual
contraction of the LV will be transduced as a ﬂow pulse
delivered to the aorta, creating, under most circumstances,
pulsatile systemic ﬂow.
Atmaximal speed, the LVend-diastolic volumedecreases
to a minimum, due to maximal decompression by the LVAD.
This is comparable to a state of “hypovolemic shock.” The
reduced preload is translated to subphysiological LV and
left atrial systolic and diastolic pressures. Furthermore, the
already failing LV exposed to reduced preload decreases its
contractility accordingtoStarling’s response. This minimizes
the increase in LV systolic pressure, resulting in a non-
signiﬁcant systolic increase in LVAD preload and output.
The systemic circulation is continuously supported by the
maximal LVAD output, preventing signiﬁcant changes in the
aortic pressure and ﬂow between systole and diastole. LV
systolic pressure does not increase above aortic pressures
and is insuﬃcient to allow aortic ejection. The LV remains
the direct source of LVAD preload but does not contribute
independently to the cardiac output.
As pump ﬂow decreases to submaximal values (10,000
to 11,000rpm), pulsatility is generated. More blood is left
in the ventricle, enhancing LV contractility as LV systolic
pressure rises. The increased LV systolic pressure translates
into increased systolic LVAD preload generating pulsatility.
Under submaximal LVAD speed, systolic LV pressure does
not increase above aortic pressure and is still insuﬃcient to
allow aortic ejection (aortic valve opening). The LV still does
not contribute independently to cardiac output.
Reducing pump speed further increases the amount of
blood left in the ventricle. LV contractility increases through
the Starling’s response, and the LV systolic pressure increases
above aortic pressure allowing aortic valve opening and
systolic ejection. Aortic valve closure (and opening) can
therefore be recognized by the reappearance of the normal
dicrotic notch in the aortic pressure curve.
2.2. Hemodynamic Impact of the LVAD on Right-Sided Cham-
bers. As previously discussed, the axial-ﬂow pumps are
directly connected to the LV through the inﬂow cannula,
making the LV the direct source of preload. The LV, in turn,
receives preload from the right ventricle (RV) through the
pulmonary circulation. This important concept is central to
optimal pump function. Right heart dysfunction (RHD) isCardiology Research and Practice 3
a frequent concern after LVAD implantation, as it occurs in
one-thirdofpatients.Itcontributessigniﬁcantlytopostoper-
ative morbidity and mortality [11]. The LVAD mechanically
unloads the LV, resulting in subphysiological left atrial and
left ventricular pressures. On the other hand, right ventric-
ular and right atrial pressures may be elevated after LVAD
implantation [5]. Excessive unloading of left heart chambers
may result in a complex biphasic eﬀect on RV function.
Following LVAD implantation, there is a signiﬁcant decrease
in mean left atrial and mean pulmonary pressures [12]. The
reducedRVafterload may thereforeimproveitsfunctionand
totaloutput.However,bowingoftheinterventricularseptum
a w a yf r o mt h er i g h tv e n t r i c l ei n t ot h ed e c o m p r e s s e dL Vm a y
reduce the eﬃciency of RV contraction by destabilizing the
hinge upon which the RV contracts [11, 12]. Moreover, the
RV may receive excessive venous return owing to the LVAD
eﬀective forward ﬂow through the systemic circulation,
resulting in RV dilatation and dysfunction [13]. Maintaining
the septum in the midline position requires maintenance
of adequate or appropriate LV volume. This can result in
suboptimal LVAD ﬂow, which prevents overcirculation that
couldoverwhelm thefunctional capacityof theRV. Ifcardiac
output decreases because of lack of LV ﬁlling due to RV
failure, high pulmonary resistance, or signiﬁcant tricuspid
regurgitation (TR), it is hazardous to attempt to improve
the patient’s condition by increasing pump speed. Without
improvement in left ventricular inﬂow, increasing the speed
will cause a further decrease in the size of the LV cavity
compounding the leftward septal shift. This further impairs
RVfunctionand increases TRseverity,decreasingthealready
compromised LV inﬂow. This worsening spiral, sometimes
referred to as the “suction cascade,” may cause the septum
to encroach upon the inﬂow cannula, increasing inﬂow
velocities, but decreasing the LVAD preload. This requires
immediate intervention to avoid a vicious cycle that can
eventually lead to a fatal outcome.
3. “Stepby Step” PreoperativeRoleof
EchocardiographyinLVADPatients
Transthoracic echocardiographic assessment of patient
undergoing VAD insertion involves aspects related both to
general echocardiographic examinations and to speciﬁc con-
siderations associated with the LVAD. We will concentrate
on speciﬁc imaging concerns pertaining to LVAD patients.
For simplicity purposes, we will divide this section in three
distinct parts: (1) preoperative evaluation; (2) postoperative
assessment; (3)long-termechocardiographicconsiderations.
3.1. Preoperative Surgical Evaluation. Pre-LVAD insertion
examination of the heart and large vessels is done for two
main purposes: (1) evaluating suitability of patient for LVAD
placement; (2) assessing signiﬁcant cardiac abnormalities
that could lead to postoperative complications. Important
preoperative imaging include the evaluation of left heart
chamber function and structure, the quantiﬁcation of RV
function and TR, and the assessment for aortic and mitral
regurgitation. Other speciﬁc LVAD concerns are thepresence
of a patent foramen ovale, or the presence of intracardiac
clots. These are routinely evaluated with transesophageal
echocardiography in the operating room.
3.1.1. Preoperative Evaluation of the Left Heart Chambers.
The evaluationofthe LV function before LVADimplantation
will most commonly show depressed function with either
a dilated or normal sized ventricle, depending on the cause
of heart failure. The LV ejection fraction (LVEF) pre-
LVAD insertion is typically <25%–30%. Signiﬁcant diastolic
dysfunction is also usually present. The presence of a restric-
tive LV diastolic physiology reﬂects increased LV and LA
pressures and, when severe, supports the indication of LVAD
implantation [14]. Another common ﬁnding in patients eli-
gible for LVAD implantation is signiﬁcant functional mitral
regurgitation, due to mitral annulus dilatation, and apical
tethering of mitral leaﬂets secondary to the geometrical
changes imposed on the left ventricle [15].
3.1.2. Right Ventricular Function and TR. The central role of
RVfunctionhasalready beendiscussedindetailemphasizing
the importance of a proper functional evaluation of the RV
before LVAD implantation. The RV is a complex structure
and is incompletely visualized in any single 2D echocar-
diographic view. Two methods are commonly used to
evaluate RV function before LVAD implantation. The ﬁrst is
semiquantitative assessment of RV function and dilatation,
using the four chambers and inﬂow views. This assessment
is based on visual appreciation of longitudinal and radial
RV motion. A more quantitative approach was recently
proposed in recent reports; the global RV fractional area
change is calculated as the RV fractional area change = (RV
diastolic area-RV systolic area)/RV diastolic area, with RV
diastolic and systolic areas traced in the 4 chamber views
[16]. An RV fractional area change (RVFAC) of 40% or
higher is normal. Typically, the RVFAC in a patient needing
an LVAD implantation is 20% to 30%. Patients with an
RVFAC <20% are more prone to postoperative RV failure.
For estimation of TR, a combination of qualitative and
quantitative methods are used as described previously [17].
More than moderate TR requires surgical correction either
through a TV annuloplasty or a tricuspid valve replacement
[18].
3.1.3. Aortic Regurgitation. Diagnosis of signiﬁcant pre- and
postoperative aortic regurgitation (AR) is crucial in patients
receiving an LVAD. The LVAD draws blood from the LV
and ejects it into the aorta creating subphysiological LV
pressures. The retrograde aorta to LV gradient increases and
continues throughout the cardiac cycle, including most of
the systolic phase. During maximal LVAD output, the aortic
valve is permanently closed, encountering this gradient
constantly. The combination of increased pressure gradient
and exposure time results in increased regurgitant volume
after LVAD insertion. The regurgitant volume increases
LVAD preload and LV dimensions and causes secondary
pump ﬂow volume upregulation. This in turn results in
further increase in blood ejection to the ascending aorta.4 Cardiology Research and Practice
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(e) (f)
Figure 1: Aortic regurgitation after implantation. Patient presented with new onset heart failure 6 months after LVAD implantation. LVAD
evaluationshowed increased power andLVADﬂow.(a)Pre-LVAD parasternallongaxisview showingmilddiastolic aortic regurgitation. (b),
(c), and (d) Immediately after LVAD, blood is pumped from the LV into the aorta creating subphysiological LV pressures. The retrograde
aorta to LV gradient increases and continues throughout the cardiac cycle, including most of the systolic phase. Aortic regurgitation has
increased in volume and takes place during most of the cardiac cycle. (e) and (f) Six months after LVAD surgery. Aortic regurgitation
deteriorated secondary to closed aortic valve encountering high retrograde pressure gradient throughout the cardiac cycle. The progressing
regurgitant volume increased left ventricular diameter, which in turn ampliﬁed LVAD preload and output. Pump output spiraled up to very
high levels, while actual systemic blood ﬂow fell. The end result was a “futile cycle” consisting of high pump ﬂow, low total cardiac output,
and high left ventricular and left atrial pressures.
Pump output spirals up to very high levels, while actual
systemic blood ﬂow falls. The increased LV dimensions may
resultinapicaltetheringofmitral leaﬂetsandfunctional MR.
The end result is a “futile cycle” consisting of high pump
ﬂow, low total cardiac output, and high LV and LA pressures
(Figure 1). In our institution, patients with signiﬁcant AR as
a result of structural problems of the valve undergo aortic
valve replacement or surgical closure of the aortic valve
leaﬂets (Park’s stitch) [19].
3.1.4. Patent Foramen Ovale (PFO). Investigation of a Patent
Foramen Ovale (PFO) should always be performed before
implantation of an LVAD. Because a PFO is common
(around 25% of the population), meticulous care should be
taken to identify its presence. We ﬁnd that the best way to
identify a PFO by TTE is with the use of contrast (agitated
saline or bubble study) concurrent with color Doppler. We
usually perform the exam in the apical four-chamber view
or the subcostal view focusing on the interatrial septum.
Patients are taught to perform standard Valsalva maneuver
before their echocardiographic examination: ﬁrst, sustained
straining against a closed epiglottis causing abdominal
distension for 10 seconds before sudden release of the
strain by deepinspiration. Adequateperformance of Valsalva
maneuver can be detected by a decrease in the left atrial
and ventricular sizes with interatrial septum bulging to the
left atrium. For contrast injection, we use an 18 French
catheter inserted at the right antecubital vein, which is
connected by an extension tube to a 3-way stopcock with
two 10mL Luer Lock syringes. One mL of patient’s blood
is drawn from the vein into a syringe containing 8mL of
sterile normal saline solution and 1mL of air. The content
is forcefully injected back and forth for few times between
the two syringes to become a cloudy and foamy pink
emulsion and then rapidly administered intravenously to
the patient at baseline, before the Valsalva maneuver. Pre-
LVAD implantation LA pressure surpasses the RA pressure.
Because of this factor, investigation of a PFO with color
Doppler echocardiography may show a left-to-right shunt,
and a bubble study may not reveal a PFO due to the
diﬃculty in producinga transient reversal of the left-to-rightCardiology Research and Practice 5
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(e) (f) (g) (h)
Figure 2: Interventricular dependency. Parasternal long axis view showing severely dilated LV (end-diastolic dimension 85mm). (b) Apical
4-chamber view showinginterventricular, interatrial septa shifted to the right, and increased tenting and annular dimensionsof mitral valve
apparatus. (c) and (d) Systolic right ventricular and right atrial pressure is increased. T h es a m ep a t i e n tt w om o n t h sa f t e rs u r g e r y .(e) End-
diastolic diameter decreased, and septal and posterior walls have thickened. (f) Interventricular and interatrial septa are now shifted to the
left. Mitral annulus and tenting area havedecreased as well as functional mitral regurgitation. (g) and (h) Systolic right ventricular and right
atrial pressures have decreased signiﬁcantly.
pressure gradient in the presence of left heart failure, even
when a Valsalva maneuver release is correctly applied. After
insertion of an LVAD, there is LV unloading with decrease of
the LA pressure. This hemodynamic change, in association
with maintained or increased right heart pressures, may
uncover the existence of the PFO, usually with the use of
intraoperativeTEE.Those hemodynamic conditionscanalso
favor a paradoxical embolism which may result in stroke
or even pump thrombosis. One of the serious and more
common consequences of this sequence of events is the
development of severe hypoxemia due to the signiﬁcant
right-to-left shunt stressing the need to evaluate for PFO
before and after LVAD implantation.
4.PostoperativeValueofEchocardiographyin
LVAD Patients
Postsurgical TTE evaluation is performed for two main
purposes: (1)to evaluate the surgical results of the LVAD
implantation; (2) to determine reasons for postoperative
hemodynamic compromises. Speciﬁcally, important routine
postoperative imaging concerns include the following: (1)
overall structure and function of left heart chambers; (2)
quantiﬁcation of RV function and TR; (3) proper inﬂow and
outﬂow cannula placement.
4.1. Postoperative Evaluation of Left Heart Chambers. After
LVAD insertion, the LV and the LA are unloaded with
a reduction in their size [20]. Neutral or slight leftward
interventricular and interatrial septa position indicates ade-
quate LV and LA decompression (Figure 2). This appearance
should persist throughout the subsequent examinations.
If the LV is not decompressed after LVAD implantation,
a rightward septum shift can be seen and suspicion of insuf-
ﬁcient device ejection, or cannula obstruction should be
immediately raised. In contrast, extreme leftward septal shift
may indicate excessive decompression due to high pump
RPM, signiﬁcant tricuspid regurgitation, or RV dysfunction.
Because LVAD promotes nonphysiological LV unloading,
common parameters for LV function assessment such as
LVEF become invalid.
4.2. Right Ventricular Function and TR. Up to one-third of
patients will present with variable degrees of RV dysfunction
following surgery [11]. This stresses the importance of
a thorough re-examination of RV function and TR severity
after LVAD insertion. The postoperative examination should
follow the same protocol described in the pre-LVAD exam-
ination section. Once identiﬁed echocardiographically, TR
severity should be assessed during pump ﬂow adjustments.
Such adjustments lead not only to the reduction of the TR
but can also improve RV function. As part of the integrated
estimationofrightheartfunction,meanpulmonarypressure
should beestimatedusing themean ofpeaksystolic tricuspid
regurgitation velocity in end expiration. The right atrial
pressure (RAP)should be estimated by the inferior vena cava
diameter and its response to inspiration as described [21].6 Cardiology Research and Practice
4.3. Assessment of Aortic and Mitral Regurgitation Severity.
Estimation of AR severity should be part of every TTE
evaluation as it may deteriorate secondary to the closed
aortic valve encountering high retrograde pressure gradient,
continuedthroughoutthecardiaccycle.Themostcommonly
used methods are visual estimation by color Doppler, the
ratio of AR jet area to the short axis area of the LVOT
at the level of the aortic annulus, and the width of the
regurgitant jet at its origin relative to the dimension of
t h eL V O Ti nt h ep a r a s t e r n a ll o n ga x i sv i e w .F o rm i t r a l
regurgitation (MR),in a normally functioning LVAD system,
functional MR is expected to decrease signiﬁcantly. When
MR persists, a thorough evaluation of its cause should
be performed. In our experience, functional MR “begets”
functional MR just as in patients without LVAD. Suboptimal
LVAD RPM setting results in increased LV dimension,
mitral valve tenting, signiﬁcant mitral regurgitation, and
volume overload of left ventricle, culminating in increasing
LV diameter and deteriorating functional MR (Figure 3).
Wheneversigniﬁcantfunctional MRisencountered,atrialof
increasing RPM under echocardiographic guidance should
be tried.
4.4. Inﬂow Cannula Evaluation. The inﬂow cannula and
its orientation within the left ventricular apex should be
visualised on the four- and two-chamber views. The cannula
should be aligned with the LV inﬂow tract. Color Doppler
is an important component of the examination. A properly
aligned inﬂow cannula should have a laminar and unidi-
rectional ﬂow from the ventricle to the device. Abnormally
high velocity or turbulent ﬂow suggests obstruction of the
inﬂow cannula. The most common reasons for obstruction
to ﬂow in the inﬂow cannula are thrombus or intermittent
obstruction of the cannula by the ventricular wall (Figure 4)
[22]. Doppler assessment of the inﬂow cannula should be
donein the four- and two-chamber views, as they are aligned
with the central axis of a properly positioned inﬂow can-
nula. Pulsed Doppler assessment should show laminar, low
velocity ﬂow, with no regurgitation. Continuous Doppler
is used for measurement of the maximal velocity along the
inﬂow pathway from the ventricle to the LVAD. Particular
attention should be paid to high velocities produced by
cannula obstruction, and regurgitant ﬂow suggestive of
pumpmalfunction.Axial-ﬂowdevicessuchastheHeartMate
II will normally show a pulsatile inﬂow pattern because
the pump inﬂow originates from the beating LV, resulting
in periodic changes in ﬂow throughout the cardiac cycle,
reaching a maximum during systole, and minimum during
diastole. This pattern is present even when the aortic valve
does not open. Axial-ﬂow devices show peak ﬁlling velocity
between 0.7 and 2.0m/s according to preload and the
remaining pumping action of the patient’s heart.
4.5. Outﬂow Cannula. Interrogation of the outﬂow cannula
by TTE is technically challenging. We advocate the use of (1)
high left parasternal long axis view, which shows the end-to-
side anastomosis of the outﬂow cannula to the midascending
aorta; (2) right parasternal view, with thepatient lying on his
right side, which shows the long axis of the outﬂow cannula
traversing from the pump towards the right aspect of the
ascending aorta. Color ﬂow, PW, and CW Doppler are used
to evaluate ﬂow patterns of the outﬂow cannula. To measure
ﬂow velocity in the outﬂow graft, the PW sample volume
should be at least 1cm proximal to the aortic anastomosis.
The peak velocity in the outﬂow graft in axial ﬂow pumps
usually ranges from 0.5 to 2.0m/s, with unidirectional and
slightly pulsatile ﬂow [23], dependent on LVAD output
and speed. Flow patterns of the aortic outﬂow cannula are
signiﬁcantly aﬀected by the angle of insertion of the LVAD
outﬂow cannula into the native aorta [24]. Connecting the
LVAD outﬂow conduit at a shallower angle to the proximal
aorta produces fewer secondary ﬂows, lower shear stress on
the aortic wall, and lowerpeak velocities. Sometimes velocity
can be measured in the right parasternal view, with the ﬂow
directed towards the transducer.
5.EvaluationofPostoperative
HemodynamicInstability
The most common reasons for hemodynamic instability
during the ﬁrst postoperative days are hypovolemia (from
intractable bleeding), acute RV dysfunction, cardiac tam-
ponade, pulmonary emboli and LVAD dysfunction, most
commonly secondary to impeller thrombosis [25].
Acute RV dysfunction can manifest itself in the previ-
ously described “suction cascade,” including dilated hypo-
contractile RV, signiﬁcant functional TR, small LV, and
intermittent inﬂow cannula obstruction by the collapsed
LV. Pulmonary embolism can cause acute RV dysfunction,
will present in a similar way, and should be considered
whenever right-sided pressures are higher than expected.
Cardiac tamponade is sometimes very diﬃcult to diagnose.
Blood collections may be loculated and conﬁned to a small
area, compressing a particular chamber. Right or left atrial
tamponade can occur with very small collections of blood.
Right ventricular tamponade may be the consequence of
a loculated substernal thrombus [25]. The unusual physiol-
ogy of the LV makes the standard Doppler assessments for
tamponade very challenging, since the device’s echogenicity
impairs thrombi visualization. On the other hand, LVAD
dysfunction or thrombosis should be suspected with the
following combination of ﬁndings: (1) rightward deviation
of the interventricular and interatrial septum as a sign of
deﬁcient unloading of the LV and left atrium; (2) signiﬁcant
functional MR, due to insuﬃcient LV unloading, mitral
annular dilatation, and apical tethering of the mitral leaﬂets;
(3) aortic valve opening every cardiac cycle due to increased
LV systolic pressure; (4) decreased LVAD ﬂow; (5) disturbed
LVAD parameters, mainly increased power intake; (6) lab-
oratory clues suggesting intravascular hemolysis (increased
LDH, plasma hemoglobin, and bilirubin with decreased
haptoglobin). This will be demonstrated by color, or PW
Doppler evaluation of the cannula. Whenever the pump’s
impeller does not rotate, the LVAD system operates as a con-
duit connecting the ascending aorta to the left ventricular
apex. Diastolic aortic pressure is higher than left ventricular
diastolic pressure, and under conditions of impaired pump
rotation, the pressure diﬀerence reverses the ﬂow from theCardiology Research and Practice 7
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Figure 3: Severe functional mitral regurgitation. A patient presenting 17 months after LVAD implantation with failure to thrive and
advanced right- and left-sided heart failure. (a) Hemodynamic right heart catheterization revealed markedly increased wedge and right
atrial and ventricular pressures. Left atrial V wave (black arrow) reaching up to 70mmHg was recorded suggesting signiﬁcant functional
mitral regurgitation. Echocardiographic examination during baseline RPM settings showed increased LV diameter (a), interventricular,
interatrial septa shifted to the right, increased mitral annular diameter and tenting diameters (b), and severe functional mitral regurgitation.
Left ventricular assist device speed was increased under echocardiographic guidance. Left ventricular middiameter decreased in size (e).
Interventricular, interatrial septa shifted to the left and mitral annular and tenting diameters decreased in size (f). Functional mitral
regurgitation severity decreased signiﬁcantly (g). Right heart catheterization in the end of echocardiographic examination showed normal
wedge, right ventricle, and right atrial pressures, and no V waves (h). Notably, cardiac output increased from 5.7 to 7.2 liters/minute after
LVAD optimization.
ascending aorta through the outﬂow and inﬂow cannula and
into the LV apex.
6.Long-TermEchocardiographic
ConsiderationsinPatientswithLVAD
T T Ei su s e di np a t i e n t so nc h r o n i cL V A Dt h e r a p yf o r
two main purposes: (1) routine LVAD optimization; (2)
assessment of clinical deterioration or abnormal LVAD
parameters associated with LVAD dysfunction.
6.1. Optimal LVAD Settings. The goal of LVAD implantation
is to increase cardiac output while decreasing ﬁlling pres-
sures. Optimal axial LVAD settings are still controversial.
While some authorsbelievethatmaximal cardiac outputand
left chamber unloading are ideal,others are concernedby the
long-term eﬀects of LVAD working at maximal output [5].8 Cardiology Research and Practice
Figure 4:Inﬂowcannulaobstruction,the“suctioncascade”.Four-chamber transthoracicviewrepresenting theclassic“suctioncascade”that
canmanifestitselfby adilatedhypocontractileRV,signiﬁcantfunctionalTR,smallleftventricle,andintermittentinﬂowcannulaobstruction
by the collapsed LV.
Possible complications of maximal LVAD output include
increased prevalence of “suction events”, hemolysis, stasis
of blood proximal to the outﬂow cannula, and end-organ
injury related to nonphysiologic continuous circulation.
The clinical implications of continuous blood ﬂow are
currently unknown and have been a matter of signiﬁcant
debate. Another possible concern is stasis of blood proximal
to the outﬂow cannula and ascending aorta anastomosis,
when there is no forward ﬂow through the aortic valve.
This stagnant column of blood may theoretically result in
thrombosis and embolism to coronaries or carotid arteries.
Although this was described in the Jarvik 2000 axial ﬂow
device, when the outﬂow cannula was anastomosed to the
descending aorta, it has never been reported so far with
ascending aortic anastomosis [5].
The implications of this debate are obvious. If maximal
cardiac outputand LV decompression are the goal, the aortic
valve should stay permanently closed, the interatrial septum
should be shifted to the left, and ﬂow proﬁle in the outﬂow
cannula will be less pulsatile. On the otherhand, ifpulsatility
is the objective, intermittent aortic valve opening, neutral
or even rightward shift of interatrial septum, and hence
more ﬂow pulsatility in the outﬂow cannula will be expected
(Figure 5).
In our institution, the usual parameters used for estima-
tion of proper LVAD function include (1) status of aortic
valveopening;(2)interatrialand(toalesserextent)interven-
tricular septum position; (3) ﬂow pulsatility in the outﬂow
cannula; (4) TR velocity; (5) estimation of right atrial
pressure; (6) LVAD system output and total cardiac output
estimation.
The aortic valve opens whenever systolic LV pressure
increases above the aortic pressure. Any reduction in LVAD
function or speed will result in reduced LV unloading,
increased LV systolic pressure reaching above aortic systolic
pressure, allowing aortic valve opening, and systolic ejection.
Increased native LV contractility (as encountered during
stress, inotropic support, or even cardiac recovery) and
increased preload may result in aortic valve opening. In case
of increased afterload, the status of aortic valve openingCardiology Research and Practice 9
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Figure 5: LVAD speed settings. Columns: (a) minimalspeed; (b) submaximalspeed; (c) maximalspeed. Rows: (1) pulsed Doppler, outﬂow
cannula; (2) M mode aortic valve. The status of aortic valve opening and aortic ﬂow pulsatility depends on pump speed and output,
LV contractility, preload, and afterload conditions. Reduction in LVAD speed to minimum will result in minimal unloading of the LV,
increased LV systolic pressure above aortic pressure allowing pulsatile ﬂow (a1), aortic valve opening during every cycle, seen in M mode
(a2). Increasing the speed to submaximal, will unload the ventricle, reduce systolic left ventricular pressure, decrease the outﬂow pulsatility
(b1), and result in intermittent aortic valve opening in M mode (b2). Increasing speed to maximum will unload the left ventricle even
further, resulting in almostcontinuous aortic ﬂow (c1), and no aortic valve opening (c2).
dependsonthesiteofdisturbance.Ifthereasonforincreased
afterload is outﬂow cannula obstruction or kinking, the left
ventricular systolic pressure will increase, but aortic pressure
will decrease resulting in aortic valve opening every cycle.
If on the other hand, the increased afterload is due to
vasoconstriction, the aortic and left ventricle pressure will
increase concomitantly, resulting in a closed aortic valve.
The position of the interatrial septum is the most sen-
sitive measure for estimating proper decompression of left
heart ﬁlling pressures. Furthermore, contrary to aortic valve
opening status, it also shows the eﬃciency of diastolic
decompression. Importantly, it should be done concurrently
with estimation of right atrial pressure (using the IVC
method) as increased RA pressure may cause leftward
deviation of interatrial septum in the presence of high left
heart ﬁlling pressure.
Pump ﬂow, although it can be extracted from the device
controller, must be directly evaluated during TTE exam-
ination. We believe that measuring the outﬂow cannula
diameter in the right parasternal view, calculating its surface
area, and multiplying it with the outﬂow cannula ﬂow
integral is the most reproducible method. For total cardiac
output, our practice is to measure the right ventricular
outﬂow tract (RVOT) diameter in the short axis view on the
levelofaortic valveand calculateitssurface area. The resultis
multiplied by the integral of ﬂow in the RVOT (on the same
view) and the heart rate.
6.2. Assessment of Recurrent Heart Failure Associated with
LVAD Dysfunction. When assessing a patient with recur-
rent heart failure symptoms, an integrated clinical and
echocardiographic management protocol is used as a guide
to recognize the cause of axial pump failure [25]. The patient
is connected to the system monitor displaying a variety
of system performance data including pump speed, power,
pulsatility index (PI), and pump ﬂow. Brieﬂy, the pump
speed will be determined during a speed ramp study. Pump
power is a direct measurement of motor voltage and current.
Increases in pump speed, ﬂow, or physiological demand will
increase pump power. Speciﬁcally, gradual power increases,
power values greater than 10–12 watts, or abrupt changes
in power should raise concern for possible thrombus inside
the pump. Whenthe LV contracts, the increase in ventricular
pressure causes an increase in pump ﬂow during systole. The
magnitude of these ﬂow changes is measured to produce the
PI. The PI represents cardiac pulsatility and is related to the
magnitudeofassistance providedbytheLVAD.Highervalues
indicatemoreventricularﬁllingorbettercontractility(pump
is providing less support to the LV), while lower values
indicate less ventricular ﬁlling or lower contractility. Pump
ﬂow is estimated based on power. Since it is a calculated
value, it becomes imprecise at low and high regions of the
power-ﬂow relationship. Therefore, any increase in power
not related to an increased ﬂow, such as thrombus, will cause
an erroneously high ﬂow. Conversely, an occlusion of ﬂow10 Cardiology Research and Practice
path (inﬂow obstruction due to malposition or suction
events) will decrease power and calculated ﬂow. In either
situation, an independent assessment of pump output using
the TTE should be performed. It is however important to
mention that no single monitor parameter is an adequate
surrogate for monitoring the clinical status of the patient.
6.3. Evaluation of LVAD Dysfunction. LVAD malfunctions
can be broadly categorized into three main groups: (1) low
echocardiographically estimated pump ﬂow and increased
powervalues;(2)lowechocardiographically estimated pump
ﬂow with normal or low power values; (3) high echocardio-
graphically estimated pump ﬂow with low echocardiograph-
ically estimated forward cardiac output.
6.3.1. Low Pump Flow with Increased Power Values. The rea-
sonsforthiscombinationarepumpfailureorincreasedafter-
load. Pump failure may result from thrombosis, mechanical
malfunction, or decreased speed settings. The echocardio-
graphic appearance ofthese etiologies includessome or all of
the following: (1) rightward deviation of the interventricular
septum; (2) signiﬁcant functional mitral regurgitation; (3)
aortic valve opening every cardiac cycle; (4) spontaneous
echo contrast in the left atrium or left ventricle; (5)
regurgitant ﬂow through the inﬂow and outﬂow cannula,
for reasons previously discussed. Reduced speed settings
will be obvious from the controler device interrogation,
while presence of left ventricular or left atrial thrombus and
increased power and controler calculated ﬂow should raise
suspicion for LVAD thrombosis. This diﬀerential diagnosis
is clinically crucial, as LVAD thrombosis may be managed
by anticoagulants or thrombolysis, while LVAD malfunction
may require urgent surgery [25]. On the other hand,
increased afterload diﬀerential diagnosis includes outﬂow
cannula obstruction, outﬂow cannula kinking, and extreme
systemic vasoconstriction [25]. Outﬂow cannula kinking
should be suspected when there is loss of Doppler signal
in the outﬂow cannula in any echocardiographic view
[23, 25]. This can be conﬁrmed by catheterization and
contrast injection [26]. In the situation of severe systemic
vasoconstriction, one should bare in mind that axial LVADs
are extremely sensitive to increased afterload, resulting
in decline in pump output. Diﬀerentiation of systemic
vasoconstriction from mechanical complication is essential
as vasoconstriction will be treated conservatively. Although
most ofthe echocardiographic criteria forLVAD dysfunction
will be present in patients with severe vasoconstriction, the
aortic valve will stay closed. PW Doppler interrogation of
the outﬂow cannula will demonstrate high velocity pulsatile
f o r w a r dﬂ o w ,a n dP Iw i l lb ei n c r e a s e d[ 25]. The reason
for this set of ﬁndings is that although LVAD output is
reduced as demonstrated by the septal shift and functional
MR, the impeller is still rotating, amplifying the pressure
wave received from the LV. Under conditions of low pump
ﬂow, the pressure in the left ventricle is higher than
normal,resultinginincreasedforward velocityintheoutﬂow
cannula. Although the pressure in the LV is higher than
normal, the pressure in the aorta is even higher, preventing
aortic valve opening and systolic ejection.
6.3.2.LowPumpFlowwithNormalCurrentand PowerValues.
The combination of low pump ﬂow with normal or low
power (and low PI) values is the result of reduced LVAD
preload. Reduced preload is most commonly encountered
with RV failure, signiﬁcant TR, or hypovolemia. Another
common reason for reduced LVAD preload is inﬂow cannula
obstruction, largely due to malposition and intermittent
obstruction by the adjacent LV walls. The apical cannula
should stay central, not abutting any wall. Color, CW,
and PW Doppler interrogation should be done as already
described. Inﬂow cannula obstruction will result in high
velocity aliased ﬂow at the oriﬁce with manifest convergence
area. Other rare reasons for reduced LVAD preload include
mitral stenosis and ventricular ﬁbrillation [27], which can
present as recurrent heart failure episodes due to loss of RV
function, resulting in reduced LVAD preload and output.
6.3.3. High Pump Flow with Low Forward Cardiac Output.
Whenever the calculated total cardiac output is lower than
the LVAD output, futile cycles should be suspected. The
most common malfunction of the older pulsatile LVAD was
inﬂow valve regurgitation, resulting in extremely high LVAD
output, with markedly reduced total cardiac output. This
combination of ﬁndings can also be encountered in patients
with severe AI.
7.Conclusion
Precise transthoracic echocardiographic monitoring is man-
datory and paramount to evaluate the performance of con-
tinuous ﬂow left ventricular assist devices. This evaluation
is essential for surgical planning and interventional success.
Standard TTE techniques allow optimal LVAD settings
during routine follow-up visits and rapid and accurate
evaluation of mechanical or systemic malfunctions.
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